Related Experiment Videos

[A clinicopathological study of nodular lymphocyte predominance Hodgkin's disease]

F Deng1, X Liu, W Tang

  • 1Department of Pathology, Zunyi Medical College, Zunyi 563003.

Insights

Nodular lymphocyte predominance Hodgkin's disease, characterized by specific L&H cells, exhibits a slow progression and favorable prognosis. This B-cell lymphoma shows distinct immunophenotypic markers and gene rearrangements.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Nodular lymphocyte predominance Hodgkin's disease (NLPHL) is a distinct subtype of Hodgkin's lymphoma.
  • Understanding its clinicopathological features is crucial for accurate diagnosis and prognosis.

Purpose of the Study:

  • To investigate the clinicopathological characteristics of nodular lymphocyte predominance Hodgkin's disease.
  • To identify key diagnostic markers and understand the disease course.

Main Methods:

  • Analysis of paraffin-embedded and frozen lymph node samples from NLPHL patients.
  • Utilized Hematoxylin and Eosin (HE) staining, immunohistochemistry (CD3, CD19, CD20, CD30, CD45RB, kappa, lambda), and polymerase chain reaction (PCR) for L&H cells.

Main Results:

  • Characteristic L&H cells were identified in a background of small lymphocytes and histiocytes.
  • L&H cells expressed CD19, CD20, CD45RB, and kappa light chain.
  • Gene rearrangements (IgH and V kappa 4 family) were detected in L&H cells, and 8/12 patients survived over 5 years.

Conclusions:

  • NLPHL demonstrates a slow disease course and a better prognosis compared to other Hodgkin's lymphoma subtypes.
  • The disease is confirmed to be a malignant lymphoma originating from B cells.
  • Immunohistochemical and molecular findings aid in definitive diagnosis and understanding pathogenesis.
Abstract

Related Concept Videos